Tag: meds
J&J’s immunology meds Stelara, Tremfya posted big revenue gains, but pricing...
Johnson & Johnson touted solid growth for its immunology meds Stelara and Tremfya in its latest quarterly results, but Bernstein analysts are spotlighting steep net pricing...
Early-stage nano-carrier uses miRNA to deploy cancer meds on contact with...
Cancer cells could play a key role in the delivery of tumor-fighting drugs, thanks to a new DNA transport system that keeps its therapeutic...